Timeline of Adverse Events during Immune Checkpoint Inhibitors for Advanced Melanoma and Their Impacts on Survival

Timeline of Adverse Events during Immune Checkpoint Inhibitors for Advanced Melanoma and Their Impacts on Survival

Immune-related adverse events (irAEs) are frequent and could be associated with improved response to immune checkpoint inhibitors (ICIs). A prospective cohort of advanced melanoma patients receiving ICI as first-line therapy was retrospectively reviewed (January 2011–February 2019). A total of 116 o...

Full description

Bibliographic Details
Main Authors: Lorena Villa-Crespo, Sebastian Podlipnik, Natalia Anglada, Clara Izquierdo, Priscila Giavedoni, Pablo Iglesias, Mireia Dominguez, Francisco Aya, Ana Arance, Josep Malvehy, Susana Puig, Cristina Carrera
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Cancers
Subjects:
immunotherapy
melanoma
dermatological adverse events
immune-related adverse events
immune checkpoint inhibitors
dermatological drug reactions
Online Access:https://www.mdpi.com/2072-6694/14/5/1237

Internet

https://www.mdpi.com/2072-6694/14/5/1237

Similar Items